NO20033653D0 - Ny filmcoating - Google Patents

Ny filmcoating

Info

Publication number
NO20033653D0
NO20033653D0 NO20033653A NO20033653A NO20033653D0 NO 20033653 D0 NO20033653 D0 NO 20033653D0 NO 20033653 A NO20033653 A NO 20033653A NO 20033653 A NO20033653 A NO 20033653A NO 20033653 D0 NO20033653 D0 NO 20033653D0
Authority
NO
Norway
Prior art keywords
film coating
new film
pharmaceutical formulations
modified release
film
Prior art date
Application number
NO20033653A
Other languages
English (en)
Other versions
NO20033653L (no
NO320358B1 (no
Inventor
Lars Johan Pontus D Hjaertstam
Jan-Erik Loefroth
Staffan Schantz
Anders Welin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0104327A external-priority patent/SE0104327D0/xx
Priority claimed from SE0104328A external-priority patent/SE0104328D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20033653D0 publication Critical patent/NO20033653D0/no
Publication of NO20033653L publication Critical patent/NO20033653L/no
Publication of NO320358B1 publication Critical patent/NO320358B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Piezo-Electric Transducers For Audible Bands (AREA)
  • Surface Treatment Of Glass Fibres Or Filaments (AREA)
NO20033653A 2001-12-19 2003-08-18 Filmcoatingsammensetning, filmbelegg og modifisert frigivelsesfarmasoytisk formulering, samt fremgangsmater for fremstilling derav NO320358B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0104327A SE0104327D0 (sv) 2001-12-19 2001-12-19 New film coating
SE0104328A SE0104328D0 (sv) 2001-12-19 2001-12-19 New film coating
PCT/GB2002/005739 WO2003051340A1 (en) 2001-12-19 2002-12-18 New film coating

Publications (3)

Publication Number Publication Date
NO20033653D0 true NO20033653D0 (no) 2003-08-18
NO20033653L NO20033653L (no) 2003-10-10
NO320358B1 NO320358B1 (no) 2005-11-28

Family

ID=26655630

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033653A NO320358B1 (no) 2001-12-19 2003-08-18 Filmcoatingsammensetning, filmbelegg og modifisert frigivelsesfarmasoytisk formulering, samt fremgangsmater for fremstilling derav

Country Status (26)

Country Link
US (2) US6827947B2 (no)
EP (2) EP1355633B1 (no)
JP (1) JP2005514386A (no)
KR (1) KR20040065989A (no)
CN (1) CN100341491C (no)
AT (1) ATE287259T1 (no)
AU (2) AU2002361447B2 (no)
BR (1) BR0206441A (no)
CA (1) CA2435729C (no)
CZ (1) CZ20031970A3 (no)
DE (2) DE60202662T2 (no)
DK (1) DK1355633T3 (no)
ES (1) ES2233876T3 (no)
HK (1) HK1058312A1 (no)
HU (1) HUP0303886A3 (no)
IL (1) IL156998A0 (no)
IS (1) IS6863A (no)
MX (1) MXPA03007156A (no)
NO (1) NO320358B1 (no)
NZ (1) NZ526926A (no)
PL (1) PL362378A1 (no)
PT (1) PT1355633E (no)
RU (1) RU2323717C2 (no)
SI (1) SI1355633T1 (no)
SK (1) SK9132003A3 (no)
WO (1) WO2003051340A1 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
KR20040065989A (ko) * 2001-12-19 2004-07-23 아스트라제네카 아베 신규의 필름 코팅
PT1476138E (pt) 2002-02-21 2012-02-14 Valeant Internat Barbados Srl Formulações de libertação modificada de pelo menos uma forma de tramadol
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating
US7080545B2 (en) * 2002-10-17 2006-07-25 Advanced Technology Materials, Inc. Apparatus and process for sensing fluoro species in semiconductor processing systems
RU2372893C2 (ru) * 2003-10-31 2009-11-20 Хексал Аг Содержащий фармацевтический агент состав с покрытием
WO2005084636A2 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited A process for the preparation of controlled-release pharmaceutical composition of metoprolol
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
DE102004035936A1 (de) * 2004-07-23 2006-03-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
RU2435573C2 (ru) * 2005-07-28 2011-12-10 ШИР ЭлЭлСи Фармацевтические составы на основе гуанфацина, подходящие для ежедневного введения в виде единичной дозированной формы
MX2008006453A (es) * 2005-11-18 2009-01-28 Accu Break Technologies Inc Formas segmentadas de dosis farmaceutica.
DE102005060393A1 (de) * 2005-12-16 2007-06-21 Add Advanced Drug Delivery Technologies Ltd. Orales Präparat mit kontrollierter Freisetzung
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
US9284307B2 (en) 2009-08-05 2016-03-15 Idenix Pharmaceuticals Llc Macrocyclic serine protease inhibitors
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
CA2784748A1 (en) 2009-12-18 2011-06-23 Idenix Pharmaceuticals, Inc. 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
EP2611796B1 (en) 2010-09-01 2016-04-20 Ambit Biosciences Corporation An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
CA2809983A1 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation Hydrobromide salts of a pyrazolylaminoquinazoline
WO2012078649A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
WO2012106299A1 (en) 2011-01-31 2012-08-09 Celgene Corporation Pharmaceutical compositions of cytidine analogs and methods of use thereof
TW201309690A (zh) 2011-02-10 2013-03-01 Idenix Pharmaceuticals Inc 巨環絲胺酸蛋白酶抑制劑，其醫藥組合物及其於治療ｈｃｖ感染之用途
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
WO2012171884A1 (en) * 2011-06-17 2012-12-20 Evonik Röhm Gmbh Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
WO2012171575A1 (en) * 2011-06-17 2012-12-20 Evonik Röhm Gmbh Coating composition suitable for pharmaceutical or nutraceutical dosage forms
EP2852586A1 (en) 2012-03-16 2015-04-01 Axikin Pharmaceuticals, Inc. 3,5-diaminopyrazole kinase inhibitors
CA2900781A1 (en) 2013-02-13 2014-08-21 Evonik Rohm Gmbh Multiparticulate pharmaceutical composition comprising a multitude of two kinds of pellets
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
US20160229866A1 (en) 2013-09-20 2016-08-11 Idenix Pharmaceuticals Inc. Hepatitis c virus inhibitors
JP5846185B2 (ja) 2013-11-21 2016-01-20 大日本印刷株式会社 貫通電極基板及び貫通電極基板を用いた半導体装置
WO2015134560A1 (en) 2014-03-05 2015-09-11 Idenix Pharmaceuticals, Inc. Solid forms of a flaviviridae virus inhibitor compound and salts thereof
KR102416358B1 (ko) 2014-03-20 2022-07-07 카펠라 테라퓨틱스, 인크. 암 치료용의 ｅｒｂｂ 티로신 키나제 억제제로서의 벤즈이미다졸 유도체
JP6568926B2 (ja) 2014-03-20 2019-08-28 カペラ セラピューティクス，インコーポレーテッド 癌の治療のためのｅｒｂｂチロシンキナーゼ阻害剤としてのベンゾイミダゾール誘導体
BR112017000468A2 (pt) * 2014-07-09 2017-11-07 Sun Pharmaceutical Ind Ltd forma de dosagem de cápsula de liberação prolongada
WO2016042565A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release 'formulation of metoprolol
ES2805528T3 (es) 2014-12-23 2021-02-12 Sma Therapeutics Inc Inhibidores de 3,5-diaminopirazol quinasa
WO2018006059A1 (en) * 2016-06-30 2018-01-04 Beckman Coulter, Inc. Chemiluminescent substrates
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB878234A (en) 1958-12-18 1961-09-27 Roehm & Haas Gmbh Pharmaceutical coating compositions
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3341338A (en) * 1965-05-28 1967-09-12 Union Carbide Corp Polysiloxane polish formulations
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4916171A (en) * 1984-07-25 1990-04-10 Rohm And Haas Company Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US5246714A (en) * 1985-10-11 1993-09-21 Aktiebolaget Hassle Drug preparation
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US4975283A (en) * 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
EP0313845A1 (en) * 1987-09-29 1989-05-03 Warner-Lambert Company Stabilization of enteric coated dosage form
US5292522A (en) * 1989-06-20 1994-03-08 Rohm Gmbh Aqueous film coating agent for solid medicaments
FR2655266B1 (fr) 1989-12-05 1992-04-03 Smith Kline French Lab Compositions pharmaceutiques a base de cimetidine.
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
PT621032E (pt) 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
CA2117546A1 (en) * 1993-08-27 1995-02-28 Takateru Muraoka Medical adhesive sheet
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
KR20040065989A (ko) * 2001-12-19 2004-07-23 아스트라제네카 아베 신규의 필름 코팅
US20030175342A1 (en) * 2002-03-14 2003-09-18 Karl Kolter Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating

Also Published As

Publication number Publication date
ES2233876T3 (es) 2005-06-16
IS6863A (is) 2003-07-01
IL156998A0 (en) 2004-02-08
PL362378A1 (en) 2004-10-18
JP2005514386A (ja) 2005-05-19
RU2323717C2 (ru) 2008-05-10
CA2435729A1 (en) 2003-06-26
KR20040065989A (ko) 2004-07-23
NZ526926A (en) 2006-02-24
AU2008207594A1 (en) 2008-09-18
HUP0303886A2 (hu) 2004-05-28
DE60202662T2 (de) 2006-01-05
AU2002361447B2 (en) 2008-05-29
CA2435729C (en) 2005-12-13
NO20033653L (no) 2003-10-10
EP1477163A1 (en) 2004-11-17
CZ20031970A3 (cs) 2003-10-15
NO320358B1 (no) 2005-11-28
CN100341491C (zh) 2007-10-10
WO2003051340A1 (en) 2003-06-26
US20040030033A1 (en) 2004-02-12
US7815938B2 (en) 2010-10-19
US20050089574A1 (en) 2005-04-28
BR0206441A (pt) 2003-12-30
HK1058312A1 (en) 2004-05-14
AU2002361447A1 (en) 2003-06-30
EP1355633B1 (en) 2005-01-19
HUP0303886A3 (en) 2005-05-30
SK9132003A3 (en) 2004-02-03
US6827947B2 (en) 2004-12-07
ATE287259T1 (de) 2005-02-15
PT1355633E (pt) 2005-05-31
RU2003125371A (ru) 2005-02-10
SI1355633T1 (en) 2005-06-30
EP1355633A1 (en) 2003-10-29
DE60202662D1 (de) 2005-02-24
MXPA03007156A (es) 2003-11-18
DK1355633T3 (da) 2005-04-04
CN1503663A (zh) 2004-06-09
DE20220902U1 (de) 2004-06-09

Similar Documents

Publication Publication Date Title
NO20033653L (no) Ny filmcoating
NZ526792A (en) Film coating composition for controlled release from pharmaceutical formulations
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
BR0315142A (pt) Cápsula, tablete, grânulo ou grânulo fino, e, cápsula de liberação prolongada
ME00482B (me) Čvrste farmaceutske kompozicije koje sadrže pregabalin sredstvo za formiranje matriksa i sredstvo za bubrenje
ATE295155T1 (de) Beschichtungen mit immobilisierten partikeln sowie verwendungen derselben
BRPI0509659A8 (pt) Processo para a preparação de uma composição de polímero de dispersão aquosa
ATE423179T1 (de) Amphiphile copolymerzusammensetzungen
DE69815003D1 (de) Stabilisierte pharmazeutische Zusammensetzung
DK2332523T4 (da) Ensartede film til hurtigtopløsende doseringsform indeholdende smagsmaskerende præparater
NO20044152L (no) Farmasoytisk preparat som inneholder vannloselige prodrugs av propofol samt fremgangsmater til administrering av samme
DK1169032T3 (da) Ketoprofen-mikrogranuler, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
ATE338796T1 (de) Beschichtungsmittel für verschmutzungsresistente beschichtungen
DE602004004784D1 (de) Aufschäumende überzugszusammensetzungen
BR0311773A (pt) composição de revestimento tendo partìculas diluentes de cloreto de polivinila
WO2003070833A3 (en) Radiation curable compositions containing copolymers of isobutylene and acrylic monomers
WO2004048425A3 (en) Polyamphoteric superabsorbent copolymers
EP1435370A4 (en) COMPOSITION OF COATING MATERIAL
SE0202353D0 (sv) New film coating
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
SE0104327D0 (sv) New film coating
CA2036402A1 (fr) Laque aerosol capillaire contenant un tetrapolymere d'acide acrylique, de n,n-dimethylacrylamide, de n-tertiobutylacrylamide et de methacrylate d'ethyle et un gaz propulseur non halogene
ATE479428T1 (de) Olanzapin enthaltende pharmazeutische zusammensetzung
ATE290387T1 (de) Ribavirin-granulat zur herstellung von filmtabletten
DK1275383T3 (da) "Modified release" farmaceutisk komposition, der indeholder Bupropion HCI som aktivt stof

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees